242 related articles for article (PubMed ID: 28718423)
1. Angiogenesis and Metabolism: Entwined for Therapy Resistance.
Jiménez-Valerio G; Casanovas O
Trends Cancer; 2017 Jan; 3(1):10-18. PubMed ID: 28718423
[TBL] [Abstract][Full Text] [Related]
2. Targeting Hypoxia-Inducible Factors for Antiangiogenic Cancer Therapy.
Rey S; Schito L; Wouters BG; Eliasof S; Kerbel RS
Trends Cancer; 2017 Jul; 3(7):529-541. PubMed ID: 28718406
[TBL] [Abstract][Full Text] [Related]
3. Metabolic effects of antiangiogenic drugs in tumors: therapeutic implications.
Quintieri L; Selmy M; Indraccolo S
Biochem Pharmacol; 2014 May; 89(2):162-70. PubMed ID: 24607274
[TBL] [Abstract][Full Text] [Related]
4. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
5. Targeting the tumor stroma in cancer therapy.
Anton K; Glod J
Curr Pharm Biotechnol; 2009 Feb; 10(2):185-91. PubMed ID: 19199950
[TBL] [Abstract][Full Text] [Related]
6. Opportunities and challenges in tumor angiogenesis research: back and forth between bench and bed.
Qin L; Bromberg-White JL; Qian CN
Adv Cancer Res; 2012; 113():191-239. PubMed ID: 22429856
[TBL] [Abstract][Full Text] [Related]
7. The great escape; the hallmarks of resistance to antiangiogenic therapy.
van Beijnum JR; Nowak-Sliwinska P; Huijbers EJ; Thijssen VL; Griffioen AW
Pharmacol Rev; 2015; 67(2):441-61. PubMed ID: 25769965
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers of evasive resistance predict disease progression in cancer patients treated with antiangiogenic therapies.
Pircher A; Jöhrer K; Kocher F; Steiner N; Graziadei I; Heidegger I; Pichler R; Leonhartsberger N; Kremser C; Kern J; Untergasser G; Gunsilius E; Hilbe W
Oncotarget; 2016 Apr; 7(15):20109-23. PubMed ID: 26956051
[TBL] [Abstract][Full Text] [Related]
9. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
Shojaei F; Ferrara N
Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic therapies: going beyond their limits.
Moserle L; Jiménez-Valerio G; Casanovas O
Cancer Discov; 2014 Jan; 4(1):31-41. PubMed ID: 24356098
[TBL] [Abstract][Full Text] [Related]
11. Resistance to antiangiogenic therapies.
Bartolotti M; Franceschi E; Poggi R; Tosoni A; Di Battista M; Brandes AA
Future Oncol; 2014 Jun; 10(8):1417-25. PubMed ID: 25052752
[TBL] [Abstract][Full Text] [Related]
12. Vascular remodeling and clinical resistance to antiangiogenic cancer therapy.
Glade Bender J; Cooney EM; Kandel JJ; Yamashiro DJ
Drug Resist Updat; 2004; 7(4-5):289-300. PubMed ID: 15533766
[TBL] [Abstract][Full Text] [Related]
13. Tumor angiogenesis revisited: Regulators and clinical implications.
Ronca R; Benkheil M; Mitola S; Struyf S; Liekens S
Med Res Rev; 2017 Nov; 37(6):1231-1274. PubMed ID: 28643862
[TBL] [Abstract][Full Text] [Related]
14. Direct Effects of Anti-Angiogenic Therapies on Tumor Cells: VEGF Signaling.
Simon T; Gagliano T; Giamas G
Trends Mol Med; 2017 Mar; 23(3):282-292. PubMed ID: 28162910
[TBL] [Abstract][Full Text] [Related]
15. Metabolic effects of anti-angiogenic therapy in tumors.
Zulato E; Curtarello M; Nardo G; Indraccolo S
Biochimie; 2012 Apr; 94(4):925-31. PubMed ID: 22245704
[TBL] [Abstract][Full Text] [Related]
16. Overcoming disappointing results with antiangiogenic therapy by targeting hypoxia.
Rapisarda A; Melillo G
Nat Rev Clin Oncol; 2012 Apr; 9(7):378-90. PubMed ID: 22525710
[TBL] [Abstract][Full Text] [Related]
17. Revisiting tumor angiogenesis: vessel co-option, vessel remodeling, and cancer cell-derived vasculature formation.
Qian CN; Tan MH; Yang JP; Cao Y
Chin J Cancer; 2016 Jan; 35():10. PubMed ID: 26747273
[TBL] [Abstract][Full Text] [Related]
18. Cancer Lipid Metabolism Confers Antiangiogenic Drug Resistance.
Iwamoto H; Abe M; Yang Y; Cui D; Seki T; Nakamura M; Hosaka K; Lim S; Wu J; He X; Sun X; Lu Y; Zhou Q; Shi W; Torimura T; Nie G; Li Q; Cao Y
Cell Metab; 2018 Jul; 28(1):104-117.e5. PubMed ID: 29861385
[TBL] [Abstract][Full Text] [Related]
19. Escaping Antiangiogenic Therapy: Strategies Employed by Cancer Cells.
Pinto MP; Sotomayor P; Carrasco-Avino G; Corvalan AH; Owen GI
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27608016
[TBL] [Abstract][Full Text] [Related]
20. Antiangiogenic Resistance: Novel Angiogenesis Axes Uncovered by Antiangiogenic Therapies Research.
Jiménez-Valerio G; Casanovas O
Curr Drug Targets; 2016; 17(15):1728-1734. PubMed ID: 26926466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]